Suppliers and packages for NDA: 207664
✉ Email this page to a colleague
207664
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
---|---|---|---|---|---|---|---|---|---|
Cipla | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 207664 | ANDA | Cipla USA Inc. | 69097-431-02 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02) | 2016-09-01 |
Cipla | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 207664 | ANDA | Cipla USA Inc. | 69097-431-05 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05) | 2016-09-01 |
Cipla | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 207664 | ANDA | Cipla USA Inc. | 69097-431-15 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15) | 2016-09-01 |
Cipla | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 207664 | ANDA | Cipla USA Inc. | 69097-432-02 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-02) | 2016-09-01 |
Cipla | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 207664 | ANDA | Cipla USA Inc. | 69097-432-05 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-05) | 2016-09-01 |
Cipla | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 207664 | ANDA | Cipla USA Inc. | 69097-432-15 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-15) | 2016-09-01 |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |